{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T12:01:46Z","timestamp":1793793706801,"version":"4.6.1"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["SBK20250405084"],"award-info":[{"award-number":["SBK20250405084"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008868","name":"Jiangsu Provincial Department of Science and Technology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008868","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52233007"],"award-info":[{"award-number":["52233007"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U25A20260"],"award-info":[{"award-number":["U25A20260"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008868","name":"Jiangsu Provincial Department of Science and Technology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008868","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-026-01672-0","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T09:03:03Z","timestamp":1777971783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Polymer\u2013mRNA complexes for monocyte-trafficked, lymph node-targeted cancer vaccination"],"prefix":"10.1038","author":[{"given":"Qiongzhe","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruonan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liguo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xijun","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0530-6661","authenticated-orcid":false,"given":"Yiming","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3705-1835","authenticated-orcid":false,"given":"Kevin C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7697-9874","authenticated-orcid":false,"given":"Chao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghua","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1870-7584","authenticated-orcid":false,"given":"Fangfang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0710-3750","authenticated-orcid":false,"given":"Congcong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4175-4741","authenticated-orcid":false,"given":"Zhiyuan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"key":"1672_CR1","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","volume":"20","author":"N Chaudhary","year":"2021","unstructured":"Chaudhary, N., Weissman, D. & Whitehead, K. A. mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat. Rev. Drug Discov. 20, 817\u2013838 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1672_CR2","doi-asserted-by":"publisher","first-page":"102214","DOI":"10.1016\/j.coi.2022.102214","volume":"77","author":"DK Edwards","year":"2022","unstructured":"Edwards, D. K. & Carfi, A. Messenger ribonucleic acid vaccines against infectious diseases: current concepts and future prospects. Curr. Opin. Immunol. 77, 102214 (2022).","journal-title":"Curr. Opin. Immunol."},{"key":"1672_CR3","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi, N., Hogan, M. J., Porter, F. W. & Weissman, D. mRNA vaccines\u2014a new era in vaccinology. Nat. Rev. Drug Discov. 17, 261\u2013279 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1672_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41392-023-01579-1","volume":"8","author":"G Zhang","year":"2023","unstructured":"Zhang, G., Tang, T., Chen, Y., Huang, X. & Liang, T. mRNA vaccines in disease prevention and treatment. Signal Transduct. Target. Ther. 8, 365 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1672_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41573-023-00859-3","volume":"23","author":"D Bitounis","year":"2024","unstructured":"Bitounis, D., Jacquinet, E., Rogers, M. A. & Amiji, M. M. Strategies to reduce the risks of mRNA drug and vaccine toxicity. Nat. Rev. Drug Discov. 23, 281\u2013300 (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1672_CR6","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41571-023-00811-9","volume":"20","author":"E Kon","year":"2023","unstructured":"Kon, E., Ad-El, N., Hazan-Halevy, I., Stotsky-Oterin, L. & Peer, D. Targeting cancer with mRNA\u2013lipid nanoparticles: key considerations and future prospects. Nat. Rev. Clin. Oncol. 20, 739\u2013754 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1672_CR7","volume":"15","author":"Y Xia","year":"2023","unstructured":"Xia, Y., Fu, S., Ma, Q., Liu, Y. & Zhang, N. Application of nano-delivery systems in lymph nodes for tumor immunotherapy. Nanomicro Lett. 15, 145 (2023).","journal-title":"Nanomicro Lett."},{"key":"1672_CR8","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.3390\/cimb44030073","volume":"44","author":"M Ald\u00e9n","year":"2022","unstructured":"Ald\u00e9n, M. et al. Intracellular reverse transcription of Pfizer BioNTech COVID-19 mRNA vaccine BNT162b2 in vitro in human liver cell line. Curr. Issues Mol. Biol. 44, 1115\u20131126 (2022).","journal-title":"Curr. Issues Mol. Biol."},{"key":"1672_CR9","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.jhep.2022.03.040","volume":"77","author":"T Boettler","year":"2022","unstructured":"Boettler, T. et al. SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis. J. Hepatol. 77, 653\u2013659 (2022).","journal-title":"J. Hepatol."},{"key":"1672_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1021\/acs.accounts.1c00601","volume":"55","author":"D Loughrey","year":"2022","unstructured":"Loughrey, D. & Dahlman, J. E. Non-liver mRNA delivery. Acc. Chem. Res. 55, 13\u201323 (2022).","journal-title":"Acc. Chem. Res."},{"key":"1672_CR11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.molmed.2022.07.009","volume":"28","author":"M Cosentino","year":"2022","unstructured":"Cosentino, M. & Marino, F. The spike hypothesis in vaccine-induced adverse effects: questions and answers. Trends Mol. Med. 28, 797\u2013799 (2022).","journal-title":"Trends Mol. Med."},{"key":"1672_CR12","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.molmed.2022.04.007","volume":"28","author":"IP Trougakos","year":"2022","unstructured":"Trougakos, I. P. et al. Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis. Trends Mol. Med. 28, 542\u2013554 (2022).","journal-title":"Trends Mol. Med."},{"key":"1672_CR13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2207841119","volume":"119","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8+ T cell response. Proc. Natl Acad. Sci. USA 119, e2207841119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1672_CR14","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41565-023-01404-4","volume":"18","author":"X Han","year":"2023","unstructured":"Han, X. et al. Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines. Nat. Nanotechnol. 18, 1105\u20131114 (2023).","journal-title":"Nat. Nanotechnol."},{"key":"1672_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk2444","volume":"10","author":"M Liu","year":"2024","unstructured":"Liu, M. et al. Lymph-targeted high-density lipoprotein-mimetic nanovaccine for multi-antigenic personalized cancer immunotherapy. Sci. Adv. 10, eadk2444 (2024).","journal-title":"Sci. Adv."},{"key":"1672_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb6981","volume":"13","author":"S Wang","year":"2021","unstructured":"Wang, S. et al. Macrophage-tumor chimeric exosomes accumulate in lymph node and tumor to activate the immune response and the tumor microenvironment. Sci. Transl. Med. 13, eabb6981 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1672_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202109984","volume":"34","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Rapid surface display of mRNA antigens by bacteria-derived outer membrane vesicles for a personalized tumor vaccine. Adv. Mater. 34, e2109984 (2022).","journal-title":"Adv. Mater."},{"key":"1672_CR18","doi-asserted-by":"publisher","first-page":"17975","DOI":"10.1021\/jacs.1c09585","volume":"143","author":"D Zhang","year":"2021","unstructured":"Zhang, D. et al. Targeted delivery of mRNA with one-component ionizable amphiphilic Janus dendrimers. J. Am. Chem. Soc. 143, 17975\u201317982 (2021).","journal-title":"J. Am. Chem. Soc."},{"key":"1672_CR19","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.1021\/jacs.2c00273","volume":"144","author":"D Zhang","year":"2022","unstructured":"Zhang, D. et al. The unexpected importance of the primary structure of the hydrophobic part of one-component ionizable amphiphilic Janus dendrimers in targeted mRNA delivery activity. J. Am. Chem. Soc. 144, 4746\u20134753 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"1672_CR20","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jconrel.2017.08.009","volume":"267","author":"H Jiang","year":"2017","unstructured":"Jiang, H., Wang, Q. & Sun, X. Lymph node targeting strategies to improve vaccination efficacy. J. Control. Release 267, 47\u201356 (2017).","journal-title":"J. Control. Release"},{"key":"1672_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202318515","volume":"63","author":"J Lei","year":"2024","unstructured":"Lei, J. et al. Development of mannosylated lipid nanoparticles for mRNA cancer vaccine with high antigen presentation efficiency and immunomodulatory capability. Angew. Chem. Int. Ed. 63, e202318515 (2024).","journal-title":"Angew. Chem. Int. Ed."},{"key":"1672_CR22","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1038\/s41590-023-01662-3","volume":"24","author":"L Zhou","year":"2023","unstructured":"Zhou, L. et al. Tumor cell-released kynurenine biases MEP differentiation into megakaryocytes in individuals with cancer by activating AhR\u2013RUNX1. Nat. Immunol. 24, 2042\u20132052 (2023).","journal-title":"Nat. Immunol."},{"key":"1672_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38444-2","volume":"14","author":"L Zhu","year":"2023","unstructured":"Zhu, L. et al. Microbiota-assisted iron uptake promotes immune tolerance in the intestine. Nat. Commun. 14, 2790 (2023).","journal-title":"Nat. Commun."},{"key":"1672_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-70916-3","volume":"14","author":"FJ Hansen","year":"2024","unstructured":"Hansen, F. J. et al. CD71 expressing circulating neutrophils serve as a novel prognostic biomarker for metastatic spread and reduced outcome in pancreatic ductal adenocarcinoma patients. Sci. Rep. 14, 21164 (2024).","journal-title":"Sci. Rep."},{"key":"1672_CR25","doi-asserted-by":"publisher","first-page":"607692","DOI":"10.3389\/fimmu.2021.607692","volume":"12","author":"PV Candelaria","year":"2021","unstructured":"Candelaria, P. V., Leoh, L. S., Penichet, M. L. & Daniels-Wells, T. R. Antibodies targeting the transferrin receptor 1 (TfR1) as direct anti-cancer agents. Front. Immunol. 12, 607692 (2021).","journal-title":"Front. Immunol."},{"key":"1672_CR26","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.clim.2006.06.010","volume":"121","author":"TR Daniels","year":"2006","unstructured":"Daniels, T. R., Delgado, T., Rodriguez, J. A., Helguera, G. & Penichet, M. L. The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin. Immunol. 121, 144\u2013158 (2006).","journal-title":"Clin. Immunol."},{"key":"1672_CR27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/s41586-024-07947-3","volume":"638","author":"D Zhang","year":"2025","unstructured":"Zhang, D. et al. Transferrin receptor targeting chimeras for membrane protein degradation. Nature 638, 787\u2013795 (2025).","journal-title":"Nature"},{"key":"1672_CR28","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-021-03227-6","volume":"592","author":"A Baeyens","year":"2021","unstructured":"Baeyens, A. et al. Monocyte-derived S1P in the lymph node regulates immune responses. Nature 592, 290\u2013295 (2021).","journal-title":"Nature"},{"key":"1672_CR29","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.cell.2024.11.031","volume":"188","author":"KY Chen","year":"2024","unstructured":"Chen, K. Y. et al. Inflammation switches the chemoattractant requirements for naive lymphocyte entry into lymph nodes. Cell 188, 1019\u20131035 (2024).","journal-title":"Cell"},{"key":"1672_CR30","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41586-024-08257-4","volume":"637","author":"A Elewaut","year":"2024","unstructured":"Elewaut, A. et al. Cancer cells impair monocyte-mediated T cell stimulation to evade immunity. Nature 637, 716\u2013725 (2024).","journal-title":"Nature"},{"key":"1672_CR31","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.4049\/jimmunol.1102744","volume":"188","author":"C Langlet","year":"2012","unstructured":"Langlet, C. et al. CD64 expression distinguishes monocyte-derived and conventional dendritic cells and reveals their distinct role during intramuscular immunization. J. Immunol. 188, 1751\u20131760 (2012).","journal-title":"J. Immunol."},{"key":"1672_CR32","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.immuni.2007.01.017","volume":"26","author":"B Le\u00f3n","year":"2007","unstructured":"Le\u00f3n, B., L\u00f3pez-Bravo, M. & Ardav\u00edn, C. Monocyte-derived dendritic cells formed at the infection site control the induction of protective T helper 1 responses against Leishmania. Immunity 26, 519\u2013531 (2007).","journal-title":"Immunity"},{"key":"1672_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11911-5","volume":"10","author":"F Zhang","year":"2019","unstructured":"Zhang, F. et al. Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers. Nat. Commun. 10, 3974 (2019).","journal-title":"Nat. Commun."},{"key":"1672_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202103258","volume":"33","author":"M Kang","year":"2021","unstructured":"Kang, M. et al. Nanocomplex-mediated in vivo programming to chimeric antigen receptor\u2013M1 macrophages for cancer therapy. Adv. Mater. 33, e2103258 (2021).","journal-title":"Adv. Mater."},{"key":"1672_CR35","doi-asserted-by":"publisher","first-page":"18100","DOI":"10.1021\/acsnano.1c06707","volume":"15","author":"Y Tang","year":"2021","unstructured":"Tang, Y. et al. Precise delivery of nanomedicines to M2 macrophages by combining \u2018eat me\/don\u2019t eat me\u2019 signals and its anticancer application. ACS Nano 15, 18100\u201318112 (2021).","journal-title":"ACS Nano"},{"key":"1672_CR36","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/mt.2012.103","volume":"20","author":"JH Graversen","year":"2012","unstructured":"Graversen, J. H. et al. Targeting the hemoglobin scavenger receptor CD163 in macrophages highly increases the anti-inflammatory potency of dexamethasone. Mol. Ther. 20, 1550\u20131558 (2012).","journal-title":"Mol. Ther."},{"key":"1672_CR37","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1021\/jacs.9b11046","volume":"142","author":"L Zheng","year":"2020","unstructured":"Zheng, L. et al. In vivo monocyte\/macrophage-hitchhiked intratumoral accumulation of nanomedicines for enhanced tumor therapy. J. Am. Chem. Soc. 142, 382\u2013391 (2020).","journal-title":"J. Am. Chem. Soc."},{"key":"1672_CR38","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1158\/1538-7445.AM2022-377","volume":"82","author":"C Liu","year":"2022","unstructured":"Liu, C., Shang, C., Ma, L., Zhou, X. & Guo, C. Abstract 377: Evaluating delivery of TFR1-targeting therapies to the CNS in a novel humanized TFR1 mouse model. Cancer Res. 82, 377\u2013377 (2022).","journal-title":"Cancer Res."},{"key":"1672_CR39","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0092-8674(04)00130-8","volume":"116","author":"Y Cheng","year":"2004","unstructured":"Cheng, Y., Zak, O., Aisen, P., Harrison, S. C. & Walz, T. Structure of the human transferrin receptor\u2013transferrin complex. Cell 116, 565\u2013576 (2004).","journal-title":"Cell"},{"key":"1672_CR40","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0092-8674(00)81151-4","volume":"93","author":"JA Lebr\u00f3n","year":"1998","unstructured":"Lebr\u00f3n, J. A. et al. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell 93, 111\u2013123 (1998).","journal-title":"Cell"},{"key":"1672_CR41","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nsmb.1772","volume":"17","author":"J Abraham","year":"2010","unstructured":"Abraham, J., Corbett, K. D., Farzan, M., Choe, H. & Harrison, S. C. Structural basis for receptor recognition by New World hemorrhagic fever arenaviruses. Nat. Struct. Mol. Biol. 17, 438\u2013444 (2010).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1672_CR42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41586-018-0249-1","volume":"559","author":"J Gruszczyk","year":"2018","unstructured":"Gruszczyk, J. et al. Cryo-EM structure of an essential Plasmodium vivax invasion complex. Nature 559, 135\u2013139 (2018).","journal-title":"Nature"},{"key":"1672_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121307","volume":"280","author":"YS Choi","year":"2022","unstructured":"Choi, Y. S. et al. Beyond hydrophilic polymers in amphiphilic polymer-based self-assembled NanoCarriers: small hydrophilic carboxylate-capped disulfide drug delivery system and its multifunctionality and multispatial targetability. Biomaterials 280, 121307 (2022).","journal-title":"Biomaterials"},{"key":"1672_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202407189","volume":"36","author":"P Zhang","year":"2024","unstructured":"Zhang, P. et al. Systemic multifunctional nanovaccines for potent personalized immunotherapy of acute myeloid leukemia. Adv. Mater. 36, e2407189 (2024).","journal-title":"Adv. Mater."},{"key":"1672_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202409590","volume":"36","author":"L Qu","year":"2024","unstructured":"Qu, L. et al. A biomimetic autophagosomes-based nanovaccine boosts anticancer immunity. Adv. Mater. 36, e2409590 (2024).","journal-title":"Adv. Mater."},{"key":"1672_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46533-z","volume":"15","author":"H Kong","year":"2024","unstructured":"Kong, H. et al. An antifouling membrane-fusogenic liposome for effective intracellular delivery in vivo. Nat. Commun. 15, 4267 (2024).","journal-title":"Nat. Commun."},{"key":"1672_CR47","doi-asserted-by":"publisher","first-page":"5357","DOI":"10.1016\/j.cell.2024.07.023","volume":"187","author":"DW Brown","year":"2024","unstructured":"Brown, D. W. et al. Safe and effective in vivo delivery of DNA and RNA using proteolipid vehicles. Cell 187, 5357\u20135375 (2024).","journal-title":"Cell"},{"key":"1672_CR48","doi-asserted-by":"publisher","first-page":"8609","DOI":"10.1021\/acs.nanolett.4c01709","volume":"24","author":"C Zhao","year":"2024","unstructured":"Zhao, C., Wang, C., Shan, W., Wang, W. & Deng, H. Fusogenic lipid nanovesicle for biomacromolecular delivery. Nano Lett. 24, 8609\u20138618 (2024).","journal-title":"Nano Lett."},{"key":"1672_CR49","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1038\/s41565-024-01785-0","volume":"19","author":"Y Zhuo","year":"2024","unstructured":"Zhuo, Y. et al. Direct cytosolic delivery of siRNA via cell membrane fusion using cholesterol-enriched exosomes. Nat. Nanotechnol. 19, 1858\u20131868 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"1672_CR50","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1021\/jacsau.1c00128","volume":"1","author":"Q Laurent","year":"2021","unstructured":"Laurent, Q. et al. Thiol-mediated uptake. JACS Au 1, 710\u2013728 (2021).","journal-title":"JACS Au"},{"key":"1672_CR51","doi-asserted-by":"publisher","first-page":"15986","DOI":"10.1021\/jacs.8b06584","volume":"140","author":"S Du","year":"2018","unstructured":"Du, S., Liew, S. S., Li, L. & Yao, S. Q. Bypassing endocytosis: direct cytosolic delivery of proteins. J. Am. Chem. Soc. 140, 15986\u201315996 (2018).","journal-title":"J. Am. Chem. Soc."},{"key":"1672_CR52","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/j.biopha.2018.09.097","volume":"108","author":"H Derakhshankhah","year":"2018","unstructured":"Derakhshankhah, H. & Jafari, S. Cell penetrating peptides: a concise review with emphasis on biomedical applications. Biomed. Pharmacother. 108, 1090\u20131096 (2018).","journal-title":"Biomed. Pharmacother."},{"key":"1672_CR53","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1021\/acscentsci.0c01648","volume":"7","author":"J Guo","year":"2021","unstructured":"Guo, J. et al. Rational design of poly(disulfide)s as a universal platform for delivery of CRISPR\u2013Cas9 machineries toward therapeutic genome editing. ACS Cent. Sci. 7, 990\u20131000 (2021).","journal-title":"ACS Cent. Sci."},{"key":"1672_CR54","doi-asserted-by":"publisher","first-page":"6611","DOI":"10.1002\/anie.201900993","volume":"58","author":"Z Shu","year":"2019","unstructured":"Shu, Z. et al. Disulfide-unit conjugation enables ultrafast cytosolic internalization of antisense DNA and siRNA. Angew. Chem. Int. Ed. 58, 6611\u20136615 (2019).","journal-title":"Angew. Chem. Int. Ed."},{"key":"1672_CR55","doi-asserted-by":"publisher","first-page":"13922","DOI":"10.1039\/D1SC04828G","volume":"12","author":"R Martinent","year":"2021","unstructured":"Martinent, R. et al. Dithiolane quartets: thiol-mediated uptake enables cytosolic delivery in deep tissue. Chem. Sci. 12, 13922\u201313929 (2021).","journal-title":"Chem. Sci."},{"key":"1672_CR56","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1021\/jacs.6b09643","volume":"139","author":"D Abegg","year":"2017","unstructured":"Abegg, D. et al. Strained cyclic disulfides enable cellular uptake by reacting with the transferrin receptor. J. Am. Chem. Soc. 139, 231\u2013238 (2017).","journal-title":"J. Am. Chem. Soc."},{"key":"1672_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202209227","volume":"61","author":"P Kanjilal","year":"2022","unstructured":"Kanjilal, P., Dutta, K. & Thayumanavan, S. Thiol-disulfide exchange as a route for endosomal escape of polymeric nanoparticles. Angew. Chem. Int. Ed. 61, e202209227 (2022).","journal-title":"Angew. Chem. Int. Ed."},{"key":"1672_CR58","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12951-021-01146-2","volume":"19","author":"T Cai","year":"2021","unstructured":"Cai, T., Liu, H., Zhang, S., Hu, J. & Zhang, L. Delivery of nanovaccine towards lymphoid organs: recent strategies in enhancing cancer immunotherapy. J. Nanobiotechnol. 19, 389 (2021).","journal-title":"J. Nanobiotechnol."},{"key":"1672_CR59","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.addr.2020.07.023","volume":"161\u2013162","author":"AJ Najibi","year":"2020","unstructured":"Najibi, A. J. & Mooney, D. J. Cell and tissue engineering in lymph nodes for cancer immunotherapy. Adv. Drug Deliv. Rev. 161\u2013162, 42\u201362 (2020).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"1672_CR60","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jconrel.2022.09.015","volume":"351","author":"Q Wang","year":"2022","unstructured":"Wang, Q. et al. Lymph node-targeting nanovaccines for cancer immunotherapy. J. Control. Release 351, 102\u2013122 (2022).","journal-title":"J. Control. Release"},{"key":"1672_CR61","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/s41565-024-01727-w","volume":"19","author":"AC Wauters","year":"2024","unstructured":"Wauters, A. C. et al. Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapy. Nat. Nanotechnol. 19, 1735\u20131744 (2024).","journal-title":"Nat. Nanotechnol."},{"key":"1672_CR62","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1146\/annurev-immunol-032713-120145","volume":"32","author":"JW Griffith","year":"2014","unstructured":"Griffith, J. W., Sokol, C. L. & Luster, A. D. Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu. Rev. Immunol. 32, 659\u2013702 (2014).","journal-title":"Annu. Rev. Immunol."},{"key":"1672_CR63","doi-asserted-by":"publisher","first-page":"3032","DOI":"10.1182\/blood.V95.10.3032","volume":"95","author":"C Murdoch","year":"2000","unstructured":"Murdoch, C. & Finn, A. Chemokine receptors and their role in inflammation and infectious diseases. Blood 95, 3032\u20133043 (2000).","journal-title":"Blood"},{"key":"1672_CR64","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abb9435","volume":"6","author":"JM Leal","year":"2021","unstructured":"Leal, J. M. et al. Innate cell microenvironments in lymph nodes shape the generation of T cell responses during type I inflammation. Sci. Immunol. 6, eabb9435 (2021).","journal-title":"Sci. Immunol."},{"key":"1672_CR65","doi-asserted-by":"publisher","first-page":"15602","DOI":"10.1073\/pnas.242614699","volume":"99","author":"H Drakesmith","year":"2002","unstructured":"Drakesmith, H. et al. The hemochromatosis protein HFE inhibits iron export from macrophages. Proc. Natl Acad. Sci. USA 99, 15602\u201315607 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1672_CR66","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2400194121","volume":"121","author":"YZ Hu","year":"2024","unstructured":"Hu, Y. Z. et al. Supramolecular assembly of polycation\/mRNA nanoparticles and in vivo monocyte programming. Proc. Natl Acad. Sci. USA 121, e2400194121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1672_CR67","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.cell.2010.09.039","volume":"143","author":"C Cheong","year":"2010","unstructured":"Cheong, C. et al. Microbial stimulation fully differentiates monocytes to DC-SIGN\/CD209+ dendritic cells for immune T cell areas. Cell 143, 416\u2013429 (2010).","journal-title":"Cell"},{"key":"1672_CR68","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.immuni.2016.12.001","volume":"45","author":"S Menezes","year":"2016","unstructured":"Menezes, S. et al. The heterogeneity of Ly6Chi monocytes controls their differentiation into iNOS+ macrophages or monocyte-derived dendritic cells. Immunity 45, 1205\u20131218 (2016).","journal-title":"Immunity"},{"key":"1672_CR69","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.immuni.2012.08.026","volume":"37","author":"E Zigmond","year":"2012","unstructured":"Zigmond, E. et al. Ly6Chi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity 37, 1076\u20131090 (2012).","journal-title":"Immunity"},{"key":"1672_CR70","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.immuni.2012.12.001","volume":"38","author":"S Yona","year":"2013","unstructured":"Yona, S. et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38, 79\u201391 (2013).","journal-title":"Immunity"},{"key":"1672_CR71","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/s41590-024-01858-1","volume":"25","author":"RA Elsner","year":"2024","unstructured":"Elsner, R. A., Smita, S. & Shlomchik, M. J. IL-12 induces a B cell-intrinsic IL-12\/IFN\u03b3 feed-forward loop promoting extrafollicular B cell responses. Nat. Immunol. 25, 1283\u20131295 (2024).","journal-title":"Nat. Immunol."},{"key":"1672_CR72","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41590-022-01163-9","volume":"23","author":"C Li","year":"2022","unstructured":"Li, C. et al. Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine. Nat. Immunol. 23, 543\u2013555 (2022).","journal-title":"Nat. Immunol."},{"key":"1672_CR73","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.3390\/ijms21093283","volume":"21","author":"E Garcia","year":"2020","unstructured":"Garcia, E. & Ismail, S. Spatiotemporal regulation of signaling: focus on T cell activation and the immunological synapse. Int. J. Mol. Sci. 21, 3283 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1672_CR74","doi-asserted-by":"publisher","first-page":"a028464","DOI":"10.1101\/cshperspect.a028464","volume":"11","author":"M Hashimoto","year":"2019","unstructured":"Hashimoto, M., Im, S. J., Araki, K. & Ahmed, R. Cytokine-mediated regulation of CD8 T-cell responses during acute and chronic viral infection. Cold Spring Harb. Perspect. Biol. 11, a028464 (2019).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1672_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110134","volume":"27","author":"P Brunner","year":"2024","unstructured":"Brunner, P., Kiwitz, L., Li, L. & Thurley, K. Diffusion-limited cytokine signaling in T cell populations. iScience 27, 110134 (2024).","journal-title":"iScience"},{"key":"1672_CR76","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1182\/blood-2018-10-881722","volume":"133","author":"RM Sterner","year":"2019","unstructured":"Sterner, R. M. et al. GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts. Blood 133, 697\u2013709 (2019).","journal-title":"Blood"},{"key":"1672_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105954","volume":"55","author":"C Zhang","year":"2020","unstructured":"Zhang, C., Wu, Z., Li, J. W., Zhao, H. & Wang, G. Q. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int. J. Antimicrob. Agents 55, 105954 (2020).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"1672_CR78","volume":"19","author":"LA Dempsey","year":"2018","unstructured":"Dempsey, L. A. Immunoregulatory itaconate. Nat. Immunol. 19, 511 (2018).","journal-title":"Nat. Immunol."},{"key":"1672_CR79","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.immuni.2020.07.014","volume":"53","author":"J Villar","year":"2020","unstructured":"Villar, J. & Segura, E. The more, the merrier: DC3s join the human dendritic cell family. Immunity 53, 233\u2013235 (2020).","journal-title":"Immunity"},{"key":"1672_CR80","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.immuni.2016.05.012","volume":"44","author":"A Terashima","year":"2016","unstructured":"Terashima, A. et al. Sepsis-induced osteoblast ablation causes immunodeficiency. Immunity 44, 1434\u20131443 (2016).","journal-title":"Immunity"},{"key":"1672_CR81","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0168-3659(99)00090-5","volume":"60","author":"WT Godbey","year":"1999","unstructured":"Godbey, W. T., Wu, K. K. & Mikos, A. G. Poly(ethylenimine) and its role in gene delivery. J. Control. Release 60, 149\u2013160 (1999).","journal-title":"J. Control. Release"},{"key":"1672_CR82","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0168-3659(03)00076-2","volume":"89","author":"K Kunath","year":"2003","unstructured":"Kunath, K. et al. Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine. J. Control. Release 89, 113\u2013125 (2003).","journal-title":"J. Control. Release"},{"key":"1672_CR83","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1021\/acs.jctc.5b00935","volume":"12","author":"J Lee","year":"2016","unstructured":"Lee, J. et al. CHARMM-GUI input generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM\/OpenMM simulations using the CHARMM36 additive force field. J. Chem. Theory Comput. 12, 405\u2013413 (2016).","journal-title":"J. Chem. Theory Comput."},{"key":"1672_CR84","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"1\u20132","author":"MJ Abraham","year":"2015","unstructured":"Abraham, M. J. et al. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1\u20132, 19\u201325 (2015).","journal-title":"SoftwareX"},{"key":"1672_CR85","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1021\/ct300400x","volume":"8","author":"RB Best","year":"2012","unstructured":"Best, R. B. et al. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone \u03c6, \u03c8 and side-chain \u03c71 and \u03c72 dihedral angles. J. Chem. Theory Comput. 8, 3257\u20133273 (2012).","journal-title":"J. Chem. Theory Comput."},{"key":"1672_CR86","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nmeth.4067","volume":"14","author":"J Huang","year":"2017","unstructured":"Huang, J. et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat. Methods 14, 71\u201373 (2017).","journal-title":"Nat. Methods"},{"key":"1672_CR87","doi-asserted-by":"publisher","first-page":"074101","DOI":"10.1063\/1.3073889","volume":"130","author":"G Bussi","year":"2009","unstructured":"Bussi, G., Zykova-Timan, T. & Parrinello, M. Isothermal-isobaric molecular dynamics using stochastic velocity rescaling. J. Chem. Phys. 130, 074101 (2009).","journal-title":"J. Chem. Phys."},{"key":"1672_CR88","doi-asserted-by":"publisher","first-page":"114107","DOI":"10.1063\/5.0020514","volume":"153","author":"M Bernetti","year":"2020","unstructured":"Bernetti, M. & Bussi, G. Pressure control using stochastic cell rescaling. J. Chem. Phys. 153, 114107 (2020).","journal-title":"J. Chem. Phys."},{"key":"1672_CR89","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H","volume":"18","author":"B Hess","year":"1997","unstructured":"Hess, B., Bekker, H., Berendsen, H. J. C. & Fraaije, J. G. E. M. LINCS: a linear constraint solver for molecular simulations. J. Comput. Chem. 18, 1463\u20131472 (1997).","journal-title":"J. Comput. Chem."},{"key":"1672_CR90","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/pro.3235","volume":"27","author":"TD Goddard","year":"2018","unstructured":"Goddard, T. D. et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 27, 14\u201325 (2018).","journal-title":"Protein Sci."},{"key":"1672_CR91","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14, 33\u201338 (1996).","journal-title":"J. Mol. Graph."},{"key":"1672_CR92","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s41551-020-0599-5","volume":"4","author":"L Li","year":"2020","unstructured":"Li, L. et al. Burst release of encapsulated annexin A5 in tumours boosts cytotoxic T-cell responses by blocking the phagocytosis of apoptotic cells. Nat. Biomed. Eng. 4, 1102\u20131116 (2020).","journal-title":"Nat. Biomed. Eng."}],"updated-by":[{"DOI":"10.1038\/s41551-026-01710-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000}}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01672-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01672-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01672-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:03:08Z","timestamp":1779433388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-026-01672-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":92,"alternative-id":["1672"],"URL":"https:\/\/doi.org\/10.1038\/s41551-026-01672-0","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41551-026-01710-x","URL":"https:\/\/doi.org\/10.1038\/s41551-026-01710-x","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Z.Z., C.X., R.Y., Q.R. and F.M. have filed a provisional patent (China, CN202510375982.0) related to DTC-modified PEI for mRNA delivery, which is relevant to the mRNA delivery platform investigated in this study. K.R. is a co-founder of Catug Biotechnology Co., Ltd, and X.P. is an employee of Catug Biotechnology Co., Ltd, which is involved in the synthesis of mRNA used in this work. B.Y. is the founder of Suzhou Abogen Biosciences, and L.D. and P.G. are employees of Suzhou Abogen Biosciences. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}